Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
590.00    10.00 (1.72%)
Bid:
580.00
Ask:
600.00
Spread: 20.00 (3.448%)
Market Cap: £198.37m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Strong Nuclear Orders for Avingtrans

16 Apr 2026 07:00

RNS Number : 6370A
Avingtrans PLC
16 April 2026
 

16 April 2026

 

Avingtrans plc

 

("Avingtrans", the "Company", or the "Group")

 

Strong Nuclear Orders for Avingtrans

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce that its Advanced Engineering Systems (AES) division is reporting strong growth prospects across its businesses, driven by a keen focus on emerging opportunities in global nuclear markets.

 

The division, which has a strong heritage in the nuclear engineering sector, has seen a significant uptick in demand for its mission critical products, driven by a combination of influences including renewed global focus on energy security, decarbonisation, and the need to power the infrastructure behind AI and digital transformation.

 

Since the turn of the year, Avingtrans' AES division has secured orders worth more than £10m for nuclear applications - including a £3m contract for a Reactor Water Cleanup Pump for the Iberdrola Cofrentes Nuclear Power Plant in Spain, and a series of long-lead items for prototype pumps for next generation, smaller-scale nuclear technology projects - as well as a growing pipeline of opportunities which support current market expectations.

 

Austen Adams, COO of Avingtrans, said: "Avingtrans' businesses enjoy a distinctive position in nuclear markets, supporting customers across the whole nuclear lifecycle; from support for legacy nuclear power infrastructure, to new build sites, novel nuclear technologies, and decommissioning programmes.

 

"This gives us a unique perspective on the market.

 

"At the turn of the century, the focus was very much on maintenance and decommissioning legacy infrastructure but, in recent years, we have seen a renewed desire to develop new-build nuclear as a sustainable, decarbonised energy source. This has only accelerated in the wake of recent geopolitical instability, with countries around the world seeking to reduce their reliance on third-countries for their energy supplies.

 

"It is a shift that is also being accentuated by the AI and digital revolution, with data centres being built at an incredible rate, supported by US government investment and greater deregulation. While delivery of specialist cooling technologies creates opportunities for some of our businesses, data centres are also energy hungry, creating the perfect conditions for wide-scale adoption of new technologies - such as small modular reactors (SMR) - that can be scaled relatively quickly, and secure energy supplies locally, without overwhelming distribution networks.

 

"Avingtrans' businesses are already well advanced developing prototypes for one of the world's leading SMR companies and we expect this to be just the start of a significant increase in market activity across the industry."

 

Avingtrans' businesses operating across the nuclear and digital sectors include: Booth Industries (nuclear new build and fusion technologies); Hayward Tyler (nuclear new build, fusion and life extension); Energy Steel (nuclear new build, life extension and decommissioning); HT Fluid Handling (life extension and decommissioning); Metalcraft (nuclear new build, fusion, decommissioning and data centre cooling); and Ormandy Rycroft (data centre cooling).

 

 

Enquiries:

 

Avingtrans plc

01354 692 391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

Austen Adams, Chief Operating Officer

 

 

 

Singer Capital Markets (Nominated Adviser and Broker)

020 7496 3000

Shaun Dobson

Alex Bond

 

 

IFC Advisory (Financial PR)

 

020 3934 6632

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

 

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging and highly regulated markets.

 

Slack and Parr - Kegworth, UK

Focused on the design, manufacture and servicing of advanced precision gear metering pumps, industrial dosing pumps and hydraulics flow divider solutions.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

 

Stainless Metalcraft Ltd - Chatteris, UK

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast & explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

 

Ormandy Group - Bradford, UK

Designs, manufactures and services off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products.

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc - Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

Adaptix Ltd - Oxford & Edinburgh, UK

Designs and manufactures novel 3D X-ray systems, with imaging from a stationary source, at a significantly lower dose than CT. Markets include orthopaedics, veterinary and non-destructive evaluation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVOVRNKUSAAR
Date   Source Headline
28th Mar 20083:16 pmRNSHolding(s) in Company
28th Mar 20083:12 pmRNSHolding(s) in Company
10th Mar 20085:30 pmRNSBoard composition
27th Feb 20087:00 amRNSInterim Results
22nd Feb 200810:52 amRNSAppointment of Director
28th Jan 20084:56 pmRNSHolding(s) in Company
25th Jan 20083:16 pmRNSHolding(s) in Company
23rd Jan 20081:01 pmRNSHolding(s) in Company
23rd Jan 20081:00 pmRNSHolding(s) in Company
16th Jan 200811:41 amPRNRe Contract
2nd Jan 20084:23 pmRNSHolding(s) in Company
20th Dec 20075:22 pmRNSDirector/PDMR Shareholding
18th Dec 20072:46 pmRNSTrading Statement
13th Nov 20073:44 pmRNSAdditional Listing
7th Nov 20074:06 pmRNSAnnual Report and Accounts
19th Oct 20073:43 pmPRNAGM Statement
11th Oct 200712:19 pmRNSHolding(s) in Company
13th Sep 20072:55 pmRNSHolding(s) in Company
13th Sep 20077:00 amPRNFinal Results
14th Aug 20072:41 pmRNSAIM Rule 26 Compliance
24th Jul 20071:18 pmRNSDirector Declaration -Amendmt
23rd Jul 20075:24 pmRNSDirector Declaration
7th Jun 200710:59 amPRNInvestment & Trading Update
1st Jun 200710:46 amRNSHolding(s) in Company
31st May 20077:00 amRNSTotal Voting Rights
17th May 20074:58 pmRNSHolding(s) in Company
10th May 20077:01 amRNSDirector/PDMR Shareholding
2nd May 20072:47 pmRNSHolding(s) in Company
2nd May 20077:10 amRNSTrading Statement
1st May 20073:14 pmRNSHolding(s) in Company
20th Apr 200710:56 amRNSHolding(s) in Company
22nd Mar 20079:49 amRNSHolding(s) in Company
22nd Mar 20079:46 amRNSHolding(s) in Company
9th Mar 200712:00 pmRNSHolding(s) in Company
7th Mar 20073:43 pmRNSHolding(s) in Company
21st Feb 20077:00 amPRNInterim Results
6th Feb 20075:20 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSChange of Adviser
4th Jan 20077:00 amPRNTrading Update
21st Dec 200612:08 pmRNSTotal Voting Rights
21st Dec 200610:14 amRNSDirector/PDMR Shareholding
12th Dec 20061:25 pmRNSHolding(s) in Company
29th Nov 20065:23 pmRNSAdditional Listing
12th Oct 20062:49 pmPRNAGM Statement
5th Oct 20063:31 pmRNSHolding(s) in Company
2nd Oct 20062:00 pmRNSAnnual Report and Accounts
22nd Sep 20069:14 amPRNCompletion of Acquisition
15th Sep 20067:00 amPRNAcquisition & Placing
14th Sep 20065:34 pmRNSDirector/PDMR Shareholding
6th Jul 20067:00 amPRNTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.